Advertisement

4 Responses

  1. Kim
    Kim January 28, 2014 at 6:35 am | | Reply

    A much appreciated guest post. Thank you.

  2. Dan
    Dan January 28, 2014 at 10:48 am | | Reply

    Diabetes is a condition that has a focus on the detail. It is 24/7 and 365 nonstop. Interoperability has a starting point. What patient data is contained within the piece of equipment which we are utilizing? Does the ability exist to transfer the patient data from the equipment to an Excel spreadsheet for further analysis? It is the data within the blood glucose meter, continuous glucose meter, etc. that is critical to our ability to manage T1D. Meaning the patient and the physician can examine the same data to determine a better prescriptive approach to improve our outcomes! The FDA could add the requirement for the ability to download, transfer, etc., to an Excel spreadsheet as a suggestion. As always have a great day and thanks for the post.
    Dan

  3. FDA on Diabetes Innovation: Tackling Accuracy &...

    [...] We were so pleased to host two key individuals from the FDA at this year's DiabetesMine Innovation Summit: Courtney Lias, Director of CDRH/Division of Chemistry and Toxicology (who gave one of the opening talks updating us on FDA progress), and her colleague Stayce Beck, head of the FDA's artificial pancreas team. Their involvement in this…  [...]

  4. kristin
    kristin March 19, 2014 at 10:56 am | | Reply

    The following links are not working: Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use and Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use

    Please update. Thanks!

Leave a Reply